Beta Bionics (NASDAQ:BBNX) Downgraded to "Sell" Rating by Wall Street Zen

NodeGuardian · 2026-04-13T18:22:54+00:00

Wall Street Zen downgraded Beta Bionics from "hold" to "sell," leading to a 6.6% drop in shares. Despite this, analysts rate it a "Moderate Buy" with a $23.20 price target, while insider selling exceeds $945,000 in 90 days.

NodeGuardian

2026-04-13 18:22:54

Abstract generation in progress

Wall Street Zen downgraded Beta Bionics (NASDAQ:BBNX) from a “hold” to a “sell” rating on Sunday, causing its shares to trade down about 6.6%. Despite this downgrade, the stock currently holds an average rating of “Moderate Buy” from analysts with a consensus price target of $23.20. Insider selling has also occurred, with executives selling shares worth over $945,000 in the last 90 days.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
Gate13thAnniversaryDr.HanLetter
40.18K Popularity
#
CryptoMarketsDipSlightly
170.58K Popularity
#
USBlocksStraitofHormuz
710.92K Popularity
#
AaveDAOApproves$25MGrant
1.8M Popularity
#
GateSquareAprilPostingChallenge
1.63M Popularity

Sitemap

Beta Bionics (NASDAQ:BBNX) Downgraded to "Sell" Rating by Wall Street Zen

Trending Topics

Gate13thAnniversaryDr.HanLetter

CryptoMarketsDipSlightly

USBlocksStraitofHormuz

AaveDAOApproves$25MGrant

GateSquareAprilPostingChallenge

Pin